The FDA recently authorized two antiviral pills, Pfizer’s Paxlovid and Merck’s Lagevrio, to treat Covid-19. The treatments can reduce the risk of death in high-risk patients by up to 89% and 30%, respectively. These drugs could effectively end… Read More »
In November, a district court judge in Northern California dismissed a lawsuit those firms had filed against the U.S. Patent and Trademark Office. They were trying to strip away USPTO’s discretionary authority to consider – or not… Read More »
Sonos is a clear American success story. It has grown into a multi-billion-dollar audio business, with a well-recognized brand, and products loved by millions of consumers. In the process it has done what so many U.S. businesses… Read More »
Many pharmacies across the nation are sold out of Covid-19 rapid diagnostic tests, making it exceedingly difficult for Americans to contain the spread of the Omicron variant of SARS-CoV-2, the virus that causes Covid-19. Similar shortages and… Read More »
Friday, February 4, marked the deadline for submission of comments on the latest iteration of the Joint Department of Justice (DOJ)-U.S. Patent and Trademark Office (USPTO)-National Institute of Standards and Technology (NIST) Policy Statement on Remedies for Standards-Essential Patents… Read More »
Big Tech has long felt free to help itself to the good ideas of smaller companies. It’s bad enough that these giants fiercely contest the efforts of inventors to receive fair compensation — a courtroom mismatch between… Read More »
The Biden administration’s draft revision to a US policy statement on FRAND licensing negotiations and SEP remedies attracted 144 comments as of the deadline, which was Friday. In the submissions, many major corporations, research institutions, interest groups… Read More »
Proposed policy changes on patents essential to industry standards threaten the standardized technology ecosystem, a bipartisan group of patent office and Justice Department antitrust leaders are warning. A draft statement the Biden administration released in December is a “solution… Read More »
The Biden administration’s policy statement warning of harm from injunctions based on standard-essential patents has been decried by patent owners and former officials as a threat to innovation and the economy, but praised by tech and auto… Read More »
The Biden Administration’s comment period on its proposed policy statement on standard-essential patents generated an outpouring of opposition from national security experts, current and former government leaders of both parties, academics, inventors and entrepreneurs. Some of the key comments… Read More »
